“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Monday, August 25, 2025

Pierre Fabre Pharmaceuticals


Pierre Fabre Pharmaceuticals – Product Catalog (A–Z)

  • Busilvex → Generic: busulfan (IV infusion) → Indication: Conditioning regimen before hematopoietic stem cell transplantation (CML, AML, lymphomas) → Dose: Injection concentrate 6 mg/mL

  • Javlor → Generic: vinflunine ditartrate → Indication: Advanced or metastatic urothelial carcinoma (bladder cancer) → Dose: IV infusion vials 25 mg/mL

  • Navelbine → Generic: vinorelbine tartrate → Indication: Non-small cell lung cancer (NSCLC), advanced breast cancer → Dose: Soft capsules 20 mg, 30 mg; IV solution vials 10 mg/mL

  • Picato (withdrawn in EU/US 2020) → Generic: ingenol mebutate → Indication: Actinic keratosis (dermatology) → Dose: Topical gel 150 mcg/g, 500 mcg/g (discontinued for safety reasons)

  • Trisenox (EU co-marketed) → Generic: arsenic trioxide → Indication: Acute promyelocytic leukemia (APL) → Dose: IV infusion 1 mg/mL

  • Pierre Fabre OncoSupport → Generic: nutritional and supportive oncology care products → Indication: Dietary/nutrition support in oncology → Dose: Oral nutritional supplements (varied formulations)


    • on

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)